A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies
- Status
- RECRUITING
- Phase
- PHASE1
Related studies linked through entity extraction aliases.